← Back to all trials
Active Not Recruiting
NCT05141643
Imaging Study of 18F-FAC PET Scans to Assess Standard Treatment in People With Pancreatic Cancer
Conditions: Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: EARLY_PHASE1
Enrollment: 30
Sponsor: Memorial Sloan Kettering Cancer Center
Location: Memorial Sloan Kettering Cancer Center New York New York
Summary
The purpose of this study is to find out whether a pre-treatment PET scan using the experimental imaging tracer 18F-FAC can show how much of the standard chemotherapy for PDAC may be taken up by the cancer.
Eligibility Criteria
Inclusion Criteria:
* Patients with histologically-confirmed (confirmed at MSKCC) PDAC
* Patients must be ≥ 18 years old
* Signed, written Institutional Review Board (IRB)-approved Informed Consent Form (ICF).
* Measurable or evaluable solid disease on computed tomography (CT) or magnetic resonance imaging (MRI) scan per RECIST v1.1.
* Karnofsky Performance Status ≥70%.
* Life expectancy ≥3 months.
* A negative serum pregnancy test, within 1 week of the procedure, if the patient is female of reproductive potential.
Exclusion Criteria:
* Patients who cannot undergo PET/CT scanning (i.e. because of weight limits, claustrophobia).
* Women who are pregnant or breast-feeding.
Source: ClinicalTrials.gov (NCT05141643). StuddyBuddy aggregates publicly available trial information.
